Andere Sprachen Assembly Biosciences, Inc.

Aktien

A402CB

US0453962070

ASMB

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
13.15 ^USD	+2.65%		+3.95%	+33.62%

28.03.	Assembly Biosciences, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
19.01.	Assembly Biosciences Insider kaufte Aktien im Wert von $511,264, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights	28.03.
Assembly Biosciences Announces Effective Date of Reverse Stock Split	08.02.
Assembly Biosciences Announces Effective Date of Reverse Stock Split	08.02.
Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing	19.01.
Assembly Biosciences, Inc. Provides Anticipated Development Milestones for 2024	04.01.
Assembly Biosciences Provides Anticipated Development Milestones for 2024	04.01.
Assembly Biosciences Provides Anticipated Development Milestones for 2024	04.01.
Assembly Biosciences, Inc. Appoints Tomas Cihlar to Serve on the Board	07.12.
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	10.11.
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	10.11.
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	10.11.
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	10.11.
Assembly Biosciences: Q3 Earnings Snapshot	08.11.
Assembly Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08.11.
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates	08.11.
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	08.11.
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	08.11.
Assembly Biosciences, Inc. Appoints Anuj Gaggar as Chief Medical Officer	08.11.
Nano-Cap Stock Momentum Watchlist (SING, MGRX, ICU, ASMB)	20.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Assembly Biosciences, Inc.

Aktien

A402CB

US0453962070

ASMB

Andere Sprachen

Filter